Home/Filings/4/0001213900-26-005425
4//SEC Filing

Todisco Joseph 4

Accession 0001213900-26-005425

CIK 0001410098other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 9:28 AM ET

Size

18.6 KB

Accession

0001213900-26-005425

Insider Transaction Report

Form 4
Period: 2026-01-12
Todisco Joseph
DirectorChief Executive Officer
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-01-12$7.15/sh17,417$124,532492,079 total
  • Exercise/Conversion

    Common Stock

    [F2]
    2026-01-16$3.38/sh+29,585$99,997521,664 total
  • Tax Payment

    Common Stock

    2026-01-17$6.78/sh22,665$153,669498,999 total
  • Exercise/Conversion

    Stock Option (Right to Buy Common Stock)

    [F3]
    2026-01-1629,585411,245 total
    Exercise: $3.38Exp: 2032-05-09Common Stock (29,585 underlying)
Footnotes (3)
  • [F1]This transaction is being reported late due to an inadvertent administrative error.
  • [F2]The Reporting Person acquired stock through the exercise of options granted on 5/10/2022. The Reporting Person paid the exercise price in cash. No sales of stock were made.
  • [F3]These options were granted on 5/10/2022. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.
Signature
/s/ Beth Zelnick Kaufman, attorney-in-fact|2026-01-20

Issuer

CorMedix Inc.

CIK 0001410098

Entity typeother

Related Parties

1
  • filerCIK 0001774807

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 9:28 AM ET
Size
18.6 KB